Qiagen N.V.

Qiagen N.V.

Qiagen N.V.

Date Founded



Hulsterweg 82,Venlo, Limburg 5912 PL

Type of Company


Employees (Worldwide)



Industrial Machinery & Manufacturing
Wholesale: Industrial Products & Manufacturing
Hospitals & Patient Services

Company Description

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Contact Data
Trying to get in touch with decision makers at Qiagen N.V.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees


Chief Executive Officer

Chief Financial Officer

President, Asia-Pacific

Senior Vice President, Head of Global Operations

Senior Vice President, Head of Human Resources

Senior Vice President & Head of Corporate Business Development & Intellectual Property & Litigation

Senior Vice President-Global Sales & Managing Director

Senior Vice President Life Science Business Area

Senior Vice President, BioInformatics Business Area

Paths to Qiagen N.V.
Potential Connections via
Relationship Science
Qiagen N.V.
Owners & Shareholders
Details Hidden

DKCM invests client assets using a variety of arbitrage and other event-driven strategies, including risk arbitrage transactions and investments in financially distressed companies. The firm's primary investment strategies include distressed investing, mergers and acquisitions (or risk) arbitrage, long/short equities, and convertible and volatility arbitrage. As distressed investment opportunities are identified, they are subjected to rigorous, fundamental, bottom-up analysis.

Details Hidden

PRIMECAP Management aims to provide superior long-term investment results by utilizing fundamental research and bottom-up stock picking to construct portfolios. The firm looks for stocks that will outperform the market over a three to five-year horizon. PRIMECAP Management does not have a committee or small group that decides on whether or not to invest in an idea. Each portfolio manager makes an individual decision whether or not to invest in new ideas.

Details Hidden

CGMI generally relies on fundamental analysis with supplemental technical analysis, which may include charting or cyclical review in providing their services. Personnel involved in providing investment advisory services have access to the firm’s research facilities as well as CGMI’s and their affiliates’ economists and specialists in all major industry groups.

Recent Transactions
Details Hidden

Thermo Fisher Scientific, Inc. purchases Qiagen N.V.

Details Hidden

Calibrescientific, Inc. purchases QIAGEN Canada, Inc. from Qiagen N.V.

Details Hidden

Qiagen N.V. purchases Parsagen Diagnostics, Inc. from LRVHealth Ventures LLC, LaunchCapital LLC, Mass Medical Angels LLC, Kahm Capital LLC

Transaction Advisors

Advised onQiagen NV /Synthetic DNA Business/ /Management purchases Qiagen NV /Synthetic DNA Business from Qiagen N.V.

Legal Advisor

Advised onQiagen N.V. purchases QIAGEN Marseille SA

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Qiagen N.V.

Chair of the Securities Practice Group

Advised onThermo Fisher Scientific, Inc. purchases Qiagen N.V.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Qiagen N.V.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Qiagen N.V.

Advisors & Consultants

Co-Founder at GHO Capital Partners LLP

Managing Partner at Minter Ellison


Co-Founder at QBM Cell Science, Inc.


McKesson is dedicated to delivering the vital medicines, medical supplies and information technologies that enable the health care industry to provide patients better, safer care. McKesson is made up of many businesses, all serving the health care industry. Our businesses fall into one of two primary categories: Distribution solutions. We are the largest pharmaceutical distributor in North America, distributing one-third of the medicines used every day. As one of the leading pharmaceutical companies, we supply more than 40,000 U.S. pharmacy locations, from Wal-Mart to the Department of Veterans Affairs to community pharmacies and hospitals. McKesson is also one of the leading medical supply companies and distributes medical-surgical supplies and homecare supplies. Healthcare Technology solutions. We develop and install healthcare information technology systems that eliminate the need for paper prescriptions and paper medical records. Our software and hardware are used in more than 70% of the nation's hospitals with more than 200 beds. Our hospital information system solutions include electronic health record system (EHR) and clinical decision support system such as Interqual. McKesson's Healthcare IT division also serves diverse areas within the health industry by offering solutions such as pharmacy automation and medical claims management software. McKesson publicly traded on NYSE under MCK Businesses Serving our customers—pharmacies, medical and pharmaceutical manufacturers, hospitals, and insurers—as the health care industry evolves is our primary goal. We have business lines to automate processes from medical supplies packaging to claims management, and revenue cycle management to medical imaging. McKesson's long history in pharmaceutical industry History McKesson has a long history in health care. We’ve been a trusted provider of medical supplies and goods for more than 175 years.

LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialized Centers of Excellence. Recognized for our innovation, quality, and customer convenience, LabCorp delivers timely, accurate results for improved patient care. With scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, LabCorp performs more than 1 million tests on more than 370,000 specimens each day. LabCorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. LabCorp operates a sophisticated laboratory network, with corporate headquarters in Burlington, NC, and more than 30,000 employees nationwide. Our 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH

CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Key Stats and Financials As of 2019
Market Capitalization
Total Enterprise Value
Earnings Per Share
Total Equity
Net Profit
Total Debt
Enterprise Value / Sales
Enterprise Value EBITDAOperating
TEVNet Income
Debt TEV
Three Year Compounded Annual Growth Rate Of Revenue
Details Hidden

Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany.

Details Hidden

Curetis NV engages in the manufacture, research and development, and commercialization of molecular microbiology solutions. It offers unyvero platform, which comprsises of the unyvero system with the A50 analyzer at its core, proprietary software, and single-use, application-specific cartridges. The company was founded by Johannes Bacher, Gerd Luedke and Andreas Boos on August 2007 and is headquartered in Holzgerlingen, Germany.

Details Hidden

Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.

Precision System Science Co., Ltd. Medical Products & Equipment | Matsudo, Japan

Precision System Science Co., Ltd. engages in the development, manufacture and sale of automated systems, physicochemical instruments, and reagents. It operates through the following segments: Instruments, Reagent Kits & Consumable, Maintenance, and Customized Products. The Instruments segment offers equipment for automatic DNA extraction for laboratories and clinical institutions that includes immunochemical luminescent measuring system and equipment for specimen pretreatment. The Reagent Kits & Consumable segment consists of PSS (Precision System Science) brand reagent for sample preparation and exclusively designed plastic consumables for PSS instruments. The Maintenance segment engages in the systems maintenance and sales of spare parts. The Customized Products segment sells customized automation systems and develops systems in accordance with customer specifications. The company was founded on July 17, 1985 and is headquartered in Matsudo, Japan.

MDxHealth SA Biotechnology | Herstal, Belgium

MDxHealth SA engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, The Netherlands, Belgium, Spain, Poland, Italy, Rest of EU, and Rest of the World. It offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.

Altium Ltd. Computer Software | Chatswood, Australia

Altium Ltd. engages in developing and selling of computer software for the design of electronic products. It operates through the following segments: Board and Systems; Micro-Controllers and Embedded Systems; and Makers and Content. The Board and Systems segment includes results from PCB business for the americas, EMEA, asia pacific and emerging Markets regions as well as other products sold through partner channels. The Micro-Controllers and Embedded Systems segment comprises of results from tasking sales, operations and research and development. The Makers and Content segment covers the results from Octopart. The company was founded by Nicholas Martin in 1985 and is headquartered in Chatswood, Australia.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Qiagen N.V.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Qiagen N.V.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Qiagen N.V..